TELA Bio (TELA) Net Margin (2018 - 2026)
TELA Bio's quarterly Net Margin came in at 64.39% in Q1 2026, down 357.0% year-on-year from 25.06% in Q1 2025, and down 42.16% quarter-over-quarter from 45.3% in Q4 2025.
TELA Bio has reported Net Margin for 9 years, with the latest figure at 64.39% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 357.0% year-over-year to 64.39%; the trailing twelve-month figure through Mar 2026 stood at 49.81% (down 4280.0% YoY), and the FY2025 full-year result was 48.89%, down 4998.0% from the prior year.
- Net Margin for Q1 2026 stood at 64.39%, down from 45.3% in the prior quarter.
- The five-year high for Net Margin was 165.72% in Q4 2024, with the low at 130.66% in Q1 2022.
- Average Net Margin over 5 years is 60.49%, with a median of 76.5% recorded in 2023.
- Year-over-year, Net Margin surged 24587 bps in 2024 and tumbled 21102 bps in 2025.
- Tracing TELA's Net Margin over 5 years: stood at 91.32% in 2022, then grew by 12 bps to 80.14% in 2023, then jumped by 307 bps to 165.72% in 2024, then tumbled by 127 bps to 45.3% in 2025, then sank by 42 bps to 64.39% in 2026.
- The last three Net Margin figures came in at 64.39% (Q1 2026), 45.3% (Q4 2025), and 41.58% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -64.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.39% |
| Dec 31, 2025 | -45.30% |
| Sep 30, 2025 | -41.58% |
| Jun 30, 2025 | -49.13% |
| Mar 31, 2025 | -60.82% |
| Dec 31, 2024 | 165.72% |
| Sep 30, 2024 | -54.71% |
| Jun 30, 2024 | -78.30% |
| Mar 31, 2024 | -34.10% |
| Dec 31, 2023 | -80.14% |
| Sep 30, 2023 | -76.50% |
| Jun 30, 2023 | -80.45% |
| Mar 31, 2023 | -104.96% |
| Dec 31, 2022 | -91.32% |
| Sep 30, 2022 | -94.26% |
| Jun 30, 2022 | -107.35% |
| Mar 31, 2022 | -130.66% |
| Dec 31, 2021 | -102.41% |
| Sep 30, 2021 | -106.34% |
| Jun 30, 2021 | -108.16% |
| Mar 31, 2021 | -138.81% |
| Dec 31, 2020 | -137.46% |
| Sep 30, 2020 | -144.98% |
| Jun 30, 2020 | -173.40% |
| Mar 31, 2020 | -193.77% |
| Dec 31, 2019 | -153.62% |
| Sep 30, 2019 | -169.24% |
| Jun 30, 2019 | -242.90% |
| Mar 31, 2019 | -241.71% |
| Dec 31, 2018 | -385.91% |
| Sep 30, 2018 | -211.44% |